Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019596 |
---|---|
Receipt number | R000022618 |
Scientific Title | Phase II study of implantation of carmustine wafers, followed by radiation therapy and concomitant temozolomide and bevacizumab for newly diagnosed glioblastoma. |
Date of disclosure of the study information | 2016/01/14 |
Last modified on | 2018/05/05 09:07:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/11/02 10:46:24 | ||
2 | Update | 2015/11/30 11:35:59 | Interventions/Control_1 |
|
3 | Update | 2015/11/30 11:37:26 | Anticipated trial start date |
|
4 | Update | 2015/11/30 11:38:52 | Date of disclosure of the study information |
|
5 | Update | 2015/12/26 19:51:41 | Acronym Acronym |
|
6 | Update | 2015/12/26 19:53:29 | Date of disclosure of the study information |
|
7 | Update | 2016/01/19 23:12:09 | Acronym Acronym |
|
8 | Update | 2016/11/05 14:20:44 | Key exclusion criteria Key exclusion criteria |
|
9 | Update | 2017/05/28 14:50:04 | Recruitment status |
|
10 | Update | 2017/11/03 17:20:58 | Target sample size |
|
11 | Update | 2018/05/05 09:05:25 | Name of primary person or sponsor Organization |
|
12 | Update | 2018/05/05 09:07:44 | Recruitment status Last follow-up date |